This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

WILLIAM H. HAVENER, M.D.; JOHN SHEETS, M.D.; MARTIN J. COOK, M.D.

AMA Arch Ophthalmol. 1959;61(3):390-401.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Heparin therapy has been recommended for senile macular degeneration, in the belief that this treatment may improve the nutrition of the degenerating region. A recent report¹ states that more than half of a series of 23 patients treated with 100 mg. of heparin I. V. twice weekly showed eye improvement. This improvement consisted of such definite findings as increased visual acuity, disappearance of retinal hemorrhages, and shrinking of exudates. There were no control patients.

Our evaluation of heparin therapy was carried out on two separate groups of patients with senile macular degeneration. The larger group, consisting of 25 patients, were inmates of an old-folks' home. To be included in this group, the patient was required to have ophthalmoscopically visible senile macular degeneration. This excluded any patients with dense opacities of the clear ocular media. Details of each case are appended at the close of this paper. At the beginning . . . [Full Text PDF of this Article]

Author Affiliations
Columbus, Ohio

Footnotes
Submitted for publication Aug. 19, 1958.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?